EU AUTHORISES REMDESIVIR FOR COVID-19 TREATMENT

Brussels: The European Commission has authorised anti-viral drug remdesivir for the treatment against coronavirus, making it the first drug authorised at the European Union level for the treatment of COVID-19.

Stella Kyriakides, Commissioner for Health and Food Safety, said: “Today’s authorisation of a first medicine to treat COVID-19 is an important step forward in the fight against this virus... We will leave no stone unturned in our efforts to secure efficient treatments or vaccine against the coronavirus.”